-
Mashup Score: 0What Is the Difference Between Frontotemporal Dementia (FTD) and FTD With Granulin Mutations? - 1 year(s) ago
Dr. Mark Forman, Chief Medical Officer at Passage Bio, gives an overview of frontotemporal dementia (FTD) with granulin (GRN) mutations.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2What Is the Difference Between Frontotemporal Dementia (FTD) and FTD With Granulin Mutations? - 1 year(s) ago
Dr. Mark Forman, Chief Medical Officer at Passage Bio, gives an overview of frontotemporal dementia (FTD) with granulin (GRN) mutations.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0What Is the Difference Between Frontotemporal Dementia (FTD) and FTD With Granulin Mutations? - 1 year(s) ago
Dr. Mark Forman, Chief Medical Officer at Passage Bio, gives an overview of frontotemporal dementia (FTD) with granulin (GRN) mutations.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0What Is the Difference Between Frontotemporal Dementia (FTD) and FTD With Granulin Mutations? - 1 year(s) ago
Dr. Mark Forman, Chief Medical Officer at Passage Bio, gives an overview of frontotemporal dementia (FTD) with granulin (GRN) mutations.
Source: CheckRareCategories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 0What Is the Difference Between Frontotemporal Dementia (FTD) and FTD With Granulin Mutations? - 1 year(s) ago
Dr. Mark Forman, Chief Medical Officer at Passage Bio, gives an overview of frontotemporal dementia (FTD) with granulin (GRN) mutations.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0What Is the Difference Between Frontotemporal Dementia (FTD) and FTD With Granulin Mutations? - 1 year(s) ago
Dr. Mark Forman, Chief Medical Officer at Passage Bio, gives an overview of frontotemporal dementia (FTD) with granulin (GRN) mutations.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Mark Forman, MD, PhD, Chief Medical Officer at Passage Bio, gives an overview of frontotemporal dementia (FTD) with granulin (GRN) mutations. @Passage_Bio @FTDPIA https://t.co/9czAcJL39Q #globalphase1/2upliFT-Dclinicaltrial #GRN #FTD #raredisease #MarkForman #PassageBio